BREAST CANCER AND PREGNANCY


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Over the past decades, breast cancer has continued to remain the most common malignancy in women. In recent years, there has been a steady rise in the incidence of breast cancer in young women in the active reproductive period, which causes an increase in cancer diagnosis cases during the current pregnancy or shortly after its termination. The review presents the debatable issues of diagnosis, treatment policy, pregnancy, labor, and postpartum management tactics in these patients.

全文:

受限制的访问

作者简介

M. VOLOCHAYEVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: volochaeva.m@yandex.ru
Moscow

R. SHMAKOV

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: mdshmakov@mail.ru
Moscow

A. PAROKONNAYA

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences

Email: ANAPAR1@yandex.ru
Moscow

参考

  1. Breasted J. The Edwin Smith Surgical Papyrus. Chicago: University of Chicago Press; 1930; vol. 1: 363—463.
  2. Braun—Inglis C., Newton S., Hickey M. Chemotherapeutic agents. In: Mosby’s oncology nursing advisor: a comprehen sive guide to clinical practice. St. Louis: Mosby; 2009: 197-8; 223—38.
  3. Byers T.Nutrition and cancer: ten lessons fromthe20thcentury. Nutrition. 2000; 16: 561—3.
  4. Haagensen C.D., Stout A.P. Carcinoma of the breast. Results of treatment. 1935-1942. Ann. Surg. 1951; 134(2): 151—72.
  5. Луд Л.Н., Луд Н.Г. Рак молочной железы и беременность. Вестник Витебского государственного медицинского университета. 2008; 7(2): 50—9.
  6. Пароконная А.А. Рак молочной железы и беременность. В кн.: Первая Российская конференция «Рак и репродукция». М.: РОНЦ им. Н.Н.Блохина; 2011: 40—5.
  7. Woo J.C., Yu T., Hurd T.C. Breast cancer in pregnancy: a literature review. Arch. Surg. 2003; 138(1): 91—8.
  8. Oyama T., Koibuchi Y., McKee G. Core needle biopsy (CNB) as a diagnostic method for breast lesions: comparison with fine needle aspiration cytology (FNA). Breast Cancer. 2004; 11(4): 339—42.
  9. Parente J.T., Amsel M., Lerner R., Chinea F. Breast cancer associated with pregnancy. Obstet. Gynecol. 1988; 71(6, Pt 1): 861—4.
  10. King R.M., Welch J.S., Martin J.K.Jr., Coulam C.B. Carcinoma of the breast associated with pregnancy. Surg. Gynecol. Obstet. 1985; 160(3): 228—32.
  11. Tobon H., Horowitz L.F. Breast cancer during pregnancy. Breast Dis. 1993; 6: 127—34.
  12. Loibl S., von Minckwitz G., Gwyn K., Ellis P., Blohmer J.U., Schlegelberger B. et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer. 2006; 106(2): 237—46.
  13. Cardonick E., Dougherty R., Grana G., Gilmandyar D., Ghaffar S., Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010; 16(1): 76—82.
  14. Пароконная А.А. Рак молочной железы и беременность (особенности клиники, диагностики и лечения, прогноз): Дис.. д-ра мед. наук. М.; 2009.
  15. Jones A.L. Management of pregnancy-associated breast cancer. Breast. 2006; 15(Suppl. 2): 47—52.
  16. Amant F., Deckers S., Van Calsteren K., Loibl S., Halaska M., Brepoels L. et al. Breast cancer in pregnancy: Recommendations of an international consensus meeting. Eur. J. Cancer. 2010; 46(18): 3158—68.
  17. Decker S., Amant F. Breast cancer in pregnancy: a literature review. Facts,Views & Vision in ObGyn. 2009; 1(2): 130—41.
  18. Ni Mhuireachtaigh R., O’Gorman D.A. Anesthesia in pregnant patients for nonobstetric surgery. J. Clin. Anesth. 2006; 18(1): 60—6.
  19. Duncan P.G., Pope W.D., Cohen M.M., Greer N. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology. 1986; 64(6): 790—4.
  20. Mazonakis M., Varveris H., Damilakis J., Theoharopoulos N., Gourtsoyiannis N. Radiation dose to conceptus resulting from tangential breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2003; 55(2): 386—91.
  21. Weibe V.J., Sipila P.E. Pharmacology of antineoplastic agents in pregnancy. Crit. Rev. Oncol. Hematol. 1994; 16(2): 75—112.
  22. Goldhirsch A., Ingle J.N., Gelber R.D., Coates A.S., Thürlimann B., Senn H.J.; Panel members. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann. Oncol. 2009; 20(8): 1319—29.
  23. Doll D.C., Ringenberg Q.S., Yarbro J.W. Antineoplastic agents and pregnancy. Semin. Oncol. 1989; 16(5): 337—46.
  24. Zemlickis D., Lishner M., Degendorfer P., Panzarella T., Sutcliffe S.B., Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med. 1992; 152(3): 573—6.
  25. Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004; 5(5): 283—91.
  26. Ring A.E., Smith I.E., Ellis. P.A. Breast cancer and pregnancy. Ann. Oncol. 2005; 16(12): 1855—60.
  27. Mir O., Berveiller P., Ropert S., Goffinet F., Pons G., Treluyer J.M., Goldwasser F. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann. Oncol. 2008; 19(4): 607—13.
  28. Pereg D., Koren G., Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat. Rev. 2008; 34(4): 302—12.
  29. Hahn K.M., Johnson P.H., Gordon N., Kuerer H., Middleton L., Ramirez M. et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006; 107(6): 1219—26.
  30. Peccatori F.A., Azim H.A.Jr., Scarfone G., Gadducci A., Bonazzi C., Gentilini O. et al. Weekly epirubicin in the treatment of gestational breast cancer(GBC). Breast Cancer Res. Treat. 2009; 115(3): 591—4.
  31. Delle Chiaie L., Buck G., Grab D., Terinde R. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection. Ultrasound Obstet. Gynecol. 2001; 18(3): 232—6.
  32. Lydon-Rochelle M., Holt V.L., Martin D.P., Easterling T.R. Association between method of delivery and maternal rehospitalization. JAMA. 2000; 283(18): 2411—6.
  33. Mennes M., Stiers P., Vandenbussche E., Vercruysse G., Uyttebroeck A., De Meyer G., Van Cool S.W. Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr. Blood Cancer. 2005; 44(5): 478—86.
  34. Van Calsteren K., Heyns L., De Smet F., Van Eycken L., Gziri M.M., Van Gemert W. et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J. Clin. Oncol. 2010; 28(4): 683—9.
  35. Amant F., Van Calsteren K., Halaska M.J., Gziri M.M., Hui W., Lagae L. et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012; 13(3): 256—64.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2013